HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 20, No 12, December 2016 – Medical Imaging Technology       » Climate Change Could Hurt Coffee, Help Banana Production       » Partnerships and Innovation: Shaping the Future of Healthcare in Asia Pacific       » Chugai's Novel Antibody Technologies Put Singapore at the Centre of Fight Against Disease       » NUS Scientists Discover the "Switch" that Makes Breast Cancer Cells Aggressive      
INSIDE INDUSTRY
CLINATEC Chairman Alim-Louis Benabid Honored for Parkinson's Disease Work
Professor Alim-Louis Benabid, chairman of CLINATEC, has been honored by a second major U.S. Parkinson's disease (PD) organization for his work in treating PD.

“The Van Andel Institute's research program has a powerful impact on biomedical research in cancer and Parkinson's disease, with an emphasis on translating scientific research results into clinical applications”

Benabid received the Jay Van Andel Award for Outstanding Achievement in Parkinson's Disease Research at Van Andel Institute's Grand Challenges in Parkinson's Disease Symposium in September. The award recognizes his invention of deep brain stimulation (DBS), a highly specialized method used to treat specific kinds of neurological diseases, including Parkinson's disease.

“Dr. Benabid has made an incredible contribution to the treatment of Parkinson's disease by developing deep brain stimulation,” said Patrik Brundin, director of the Van Andel Institute's Center for Neurodegenerative Science. “Today over 140,000 advanced Parkinson's patients have undergone DBS treatment, which essentially changes the ‘electric connections’ in the brain, and they are able to move remarkably much better thanks to Dr. Benabid's invention.”

Benabid, who has received many honors during his career, was awarded the 2013 Robert H. Pritzker Prize for Leadership in Parkinson's Research from the Michael J. Fox Foundation earlier this year.

“The Van Andel Institute's research program has a powerful impact on biomedical research in cancer and Parkinson's disease, with an emphasis on translating scientific research results into clinical applications,” Benabid said. “I am honored to receive this award, and I’m proud to highlight the CLINATEC team's ongoing work on infrared brain stimulation to improve treatment of PD, and perhaps severe depression, Alzheimer's disease, Tourette's syndrome and other neurological conditions.”

Benabid helped found CLINATEC, the multidisciplinary biomedical research center created by Leti, Grenoble University Hospital, INSERM and Joseph Fourier University in 2009. The center allows medical practitioners, researchers, biologists, and technologists to collaborate on the frontier of health care and micro- and nanoelectronics. Using a unique biomedical and surgery platform, CLINATEC's main objective is to accelerate and make safer the translation of technological innovation for treating patients.

Benabid has centered his scientific activity on the approach of neurosurgical pathologies, particularly brain tumors and movement disorders. From 1989 to 2007, he was head of the Neurosurgery Department at the University Hospital of Grenoble. He currently is a professor emeritus of biophysics at Joseph Fourier University.

Source: Business Wire

Click here for the complete issue.

NEWS CRUNCH  
news Accuron Technologies' MedTech Division Invests into AWAK Technologies
news Philips introduces PerformanceBridge suite of operational performance improvement software and services for radiology departments
news Give a Gift that Will Last a Lifetime this Holiday Season with Smile Train
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Lungs & Respiratory System
February:
Cancer Research, Treatment/Technology
March:
Traditional Chinese Medicines
April:
Eye Care/ Eye Health
May:
The Piece of Your Mind - Brain Health/Science
June:
Featuring Biotech Start-Ups/Companies
July:
Food Science & Technology
August:
Diabetics Technology
September:
No. 1 Killer - Heart Diseases, Diagnosis and Treatment
October:
Skin Diseases/Allergic Reactions
November:
Diseases threatening our Children
December:
Liver Health & Treatment/Technology
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2016 World Scientific Publishing Co Pte Ltd  •  Privacy Policy